Q1 2025 Holdings
Filed 2025-05-15 | 9 holdings | $206.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc.(BEAM) | COM | 07373V105 | $88.7M | 4,540,132 | 43.0% |
| Maze Therapeutics, Inc.(MAZE) | COM | 578784100 | $45.4M | 4,120,053 | 22.0% |
| Rapport Therapeutics, Inc.(RAPP) | COM | 75383L102 | $37.5M | 3,728,738 | 18.2% |
| Erasca, Inc.(ERAS) | COM | 29479A108 | $15.1M | 11,055,554 | 7.3% |
| Verve Therapeutics, Inc. | COM | 92539P101 | $9.1M | 2,008,809 | 4.4% |
| Gossamer BIO, Inc.(GOSS) | COM | 38341P102 | $8.8M | 8,055,916 | 4.3% |
| Unity Biotechnology, Inc.(UNBX) | COM NEW | 91381U200 | $1.0M | 1,004,817 | 0.5% |
| Q32 BIO Inc.(QTTB) | COM | 746964105 | $532.0K | 320,482 | 0.3% |
| Cero Therapeutics Holdings, Inc. | COM NEW | 71902K303 | $16.1K | 22,102 | 0.0% |